Items | Survival time | Survival rate | ||
---|---|---|---|---|
Mean survival time [95% CI] (months) | 1-year survival (95% CI) | 3-year survival (95% CI) | 5-year survival (95% CI) | |
Primary hepatic neuroendocrine tumors (PH-NETs): | 30.64 (24.75–36.53) | 56.43 (48.15–64.36) | 30.00 (23.03–38.04) | 18.57 (13.00–25.82) |
Hepatocellular carcinoma (HCC in situ): | 25.11 (20.20–30.02) | 55.00 (46.74–63.00) | 21.43 (15.44–28.94) | 10.71 (6.60–16.93) |
Gastrointestinal neuroendocrine tumors in situ (GI-NETs in situ): | 41.62 (35.32–47.92) | 74.29 (66.47–80.81) | 42.86 (34.96–51.14) | 27.86 (21.10–35.80) |
Gastrointestinal neuroendocrine tumors with liver metastasis (GI-NETs-LM): | 24.81 (21.15–36.60) | 64.75 (56.51–72.20) | 30.94 (23.85–39.05) | 8. 63 (5.01–14.48) |